Last reviewed · How we verify
Bacterial vaginosis
Approved treatments
- Cleocin · Generic (originally Upjohn/Pfizer)
Lincosamide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with excellent anaerobic coverage. - Metro I.V. In Plastic Container · Baxter
- Tindamax · Mission Pharma
Tindamax works by damaging the DNA of susceptible microorganisms, ultimately leading to their death. - Solosec · Evofem Inc
Solosec works by entering susceptible microorganisms and disrupting their DNA, ultimately leading to cell death. - Metronidazol · University of Oslo
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Bacterial vaginosis patent landscape — cliff calendar, originator estates, attackable patents
- Bacterial vaginosis treatment landscape brief
- Bacterial vaginosis treatment updates RSS
Frequently asked questions about Bacterial vaginosis
What drugs treat Bacterial vaginosis?
Tracked treatments include Cleocin, Metro I.V. In Plastic Container, Tindamax, Solosec, Metronidazol.
What is the treatment for Bacterial vaginosis?
Standard treatment for Bacterial vaginosis includes Cleocin, Metro I.V. In Plastic Container, Tindamax, Solosec, Metronidazol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Bacterial vaginosis patent cliff · Bacterial vaginosis CI report
- Treatment: Cleocin · Generic (originally Upjohn/Pfizer)
- Treatment: Metro I.V. In Plastic Container · Baxter
- Treatment: Tindamax · Mission Pharma
- Treatment: Solosec · Evofem Inc
- Treatment: Metronidazol · University of Oslo
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing